Characterization of Thymoquinone-Sulfobutylether-β-Cyclodextrin Inclusion Complex for Anticancer Applications.
In this study, researchers investigated the potential of using Sulfobutylether-β-cyclodextrin (SBE-β-CD) to improve the solubility and delivery of thymoquinone (TQ), a compound derived from black seed with therapeutic and anticancer properties. Through various analyses, they found that the inclusion complexes of TQ with SBE-β-CD significantly enhanced the solubility and bioavailability of TQ. Additionally, the complexes exhibited stronger anticancer effects on various cancer cell lines compared to TQ alone. These findings suggest that SBE-β-CD may serve as an effective drug delivery system for TQ, but more research is needed to explore its mechanisms and potential side effects.
- Eid EEM et al (2023).
- Molecules.
- PubMed:
- 37241838